Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

[Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man].

HORNYKIEWICZ O.

Dtsch Med Wochenschr. 1962 Sep 7;87:1807-10. German. No abstract available.

PMID:
14448985
3.

[Dopamine and the central nervous system].

Bruno A, Cumer Bruno S.

Riv Neurobiol. 1965 Oct-Dec;11(4):813-49. Review. Italian. No abstract available.

PMID:
5329676
5.

Auto- and postsynaptic dopamine receptors in the central nervous system.

Rebec GV.

Monogr Neural Sci. 1984;10:207-23. No abstract available.

PMID:
6321971
6.

Functional aspects of the role of catecholamines in the central nervous system.

Vogt M.

Br Med Bull. 1973 May;29(2):168-72. Review. No abstract available.

PMID:
4593944
7.
8.

Pharmacology of the central nervous system.

Nelson SR, Walaszek EJ.

Prog Neurol Psychiatry. 1969;24:131-52. Review. No abstract available.

PMID:
4904798
9.

Invited Article: Nervous system pathology in sporadic Parkinson disease.

Braak H, Del Tredici K.

Neurology. 2008 May 13;70(20):1916-25. doi: 10.1212/01.wnl.0000312279.49272.9f. Review. No abstract available.

PMID:
18474848
10.

Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.

O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I.

Clin Sci (Lond). 1994 Feb;86(2):149-58.

PMID:
8143425
11.

[The effects of desmethylimipramine (Pertofran) on catecholamine metabolism in the central nervous system and the Parkinson syndrome].

Matussek N, Pohlmeier H.

Klin Wochenschr. 1965 Jul 15;43(14):797-8. German. No abstract available.

PMID:
5830732
12.

[Biological psychiatry. 1) The dopamine-acetylcholine equilibrium model].

Adèr JP.

TVZ. 1988 Jan 7;42(1):13-6. Dutch. No abstract available.

PMID:
2895504
13.

[Pathogenesis and basis of the therapy of Parkinson's disease].

van der Drift JH, Stoof JC.

Ned Tijdschr Geneeskd. 1981 Apr 18;125(16):620-5. Dutch. No abstract available.

PMID:
6113554
14.

[Age factors in the development of parkinsonism (a review of the literature)].

Frol'kis VV, Burchinskiń≠ SG, Rushkevich IuE.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1988;88(9):137-45. Review. Russian. No abstract available.

PMID:
3068941
15.

[Nitric oxide, nervous system, and Parkinson disease].

Gatto EM, Carreras MC, Poderoso JJ.

Medicina (B Aires). 1994;54(5 Pt 2):608-9. Spanish. No abstract available.

PMID:
7658994
16.
17.
19.

[Histotopography of the central nervous system structures containing catecholamines and serotonin].

Kaluza J.

Postepy Hig Med Dosw. 1971;25(2):175-94. Polish. No abstract available.

PMID:
5575443
20.

Viral infections in the central nervous system and 5-hydroxytryptamine metabolism.

Roos BE, Lycke E.

Adv Biochem Psychopharmacol. 1974;11(0):115-7. No abstract available.

PMID:
4845694

Supplemental Content

Support Center